scorecardresearch
Friday, March 29, 2024
TopicCovaxin

Topic: Covaxin

Bharat Biotech signs pact with Precisa Medicamentos for Covaxin supplies to Brazil

A team from Precisa Medicamentos visited the Bharat Biotech facility last week to discuss potential export possibilities of the vaccine, the company said in a release.

Death of Covaxin phase 3 volunteer not related to vaccine trial, says Bharat Biotech

Bharat Biotech says it has followed necessary protocol and preliminary review shows death unrelated to study. Volunteer sample being tested to determine cause of death. 

42-year-old man dies 10 days after participating in vaccine trial for Covaxin

Madhya Pradesh Medico Legal Institute Director Dr Ashok Sharma said the exact cause of the death would be known from his viscera test.

How India’s regulatory pitfalls helped Covishield and Covaxin get rapid approval

The lack of regulatory clarity coupled with lack of transparency from CDSCO raises questions on the safety and efficacy of the Covid-19 vaccine candidates.

30,000 volunteers, 60 sites — India’s 3rd Covid vaccine candidate ZYCoV-D set for final trials

Zydus Cadila chief Pankaj Patel says ZYCoV-D is easy to store, transport and inject. It can also be produced in large quantities, in a ten-dose vial format.

India to roll out Covid vaccines by 13 January, no plan yet to vaccinate children

ICMR chief Dr Balram Bargava says teachers should be the first to be vaccinated. He also says India will assist any country that wants to use CoWIN app for their vaccination programme.

India to follow ‘HCQ model’, will send Covid vaccines to neighbours after local demand is met

Officials say India 'will not be in a rush', and Bangladesh, Bhutan, Nepal, Sri Lanka will get ‘priority’ after domestic demand for the Covid vaccines is fulfilled.

This is how Bharat Biotech changed expert panel’s mind on Covaxin in a day and got approval

Minutes of the meetings held by the expert panel tell us what convinced it to change its mind about Covaxin despite incomplete phase 3 trial data.

After public spat, Bharat Biotech & SII jointly pledge smooth roll out of Covid vaccines

The joint statement comes after Bharat Biotech MD Dr Krishna Ella hit out at Serum CEO Adar Poonawalla’s comment that only Pfizer, Moderna, Oxford vaccines were effective.

Serum Institute, Bharat Biotech, Cadila vaccines — sifting science from non-science

In episode 653 of ‘Cut The Clutter’, the first in the new year, ThePrint’s Editor-in-Chief Shekhar Gupta explained working of Covaxin, Covishield & Zydus Cadila’s DNA vaccine.

On Camera

Profit margins in lottery industry are tiny. Here’s how Future Gaming paid for its electoral bonds

Neither state govts nor companies earn large profits from lotteries. However, a look at the system shows there’s ample evidence of murky dealings and financial irregularities. 

Amid plans to lift AFSPA, Army starts joint training with Jammu & Kashmir Police

In an interview with Gulistan News this week, Union Home Minister Amit Shah said the government would leave law and order to J&K Police and slowly withdraw troops.

For BJP, Kejriwal is an idea whose time has come to be destroyed

The ‘idea’ Kejriwal's politics grew around was a no-holds-barred fight against corruption. That is the reason Modi govt has now tarred him and his entire party with the same paint.